HG
Hamilton Insurance Group, Ltd.
Next earnings Aug 4, 2026 · consensus $1.07 EPS
Last earnings +2.6% on 2026-04-30
$33.55
▲ +4.13%$33.55▲ +69.42%
over 1Y
L $19.19EODHDH $33.55
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.1%
1W+6.0%
1M+9.6%
3M+17.3%
YTD+31.7%
1Y+69.4%
Buy
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 16 analysts
Buy
Specialty (re)insurer compounding book value at ~30% ROE, trading at 5.9x earnings and ~0.77x book — the market is mispricing durability.
Diluted EPS $5.55 · FY2025
The read
Quality fundamentals and an attractive price line up (~529% below fair value) — the rarer case where both the business and the entry look good.
Hamilton is firing on all cylinders at exactly the moment the market refuses to pay for it. FY2025 revenue of $2.91B (+24.7% YoY) and net income of $840M (+37.0%) extend a remarkable post-2022 ramp: revenue has more than doubled from $1.33B in FY2021 and net income has tripled off the FY2023 base, while diluted EPS jumped 51.2% to $5.55. The 28.9% net margin and 29.8% ROE are top-decile for a specialty (re)insurer, and management frames the strategy explicitly around 'sustainable underwriting profitability' rather than top-line chasing — the MD&A highlights Lloyd's Syndicate 4000 as 'among the most profitable and least volatile syndicates at Lloyd's over the last 10 years' and points to the hard US E&S market as the runway for Hamilton Select. At 5.9x trailing earnings, 0.7x sales, and roughly 0.77x book value ($2.82B equity vs. $2.17B market cap), the stock prices in a sharp earnings reversion that the filing's tone does not support.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.33B | $1.23B | $1.57B | $2.33B | $2.91B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $250M | -$29.9M | $280M | $613M | $840M |
| Diluted EPS | $1.82 | -$0.95 | $2.44 | $3.67 | $5.55 |
| Net margin | 18.7% | -2.4% | 17.8% | 26.3% | 28.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)0.16
Earnings yield37.7%
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt$150M
Net cash$913M
Piotroski F-Score6/7
Capital returns
Buyback yield5.1%
Dividend yield (est.)—
Shareholder yield5.1%
Shares Δ YoY+2.8%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRecent disclosure tone has been improving.
- 8-K Officer / director change2026-05-06
Q1 2026 results continue growth trend; underwriting and Two Sigma fund drive returns
- 10-Q Quarterly report2026-05-06
Q1 2026 results continue growth trend; underwriting and Two Sigma fund drive returns
- 8-K Earnings results2026-04-30
Q1 2026 earnings release following strong FY2025 momentum
- 8-K Agreement terminated2026-04-02
Entered new material agreement and terminated prior one; likely credit facility refresh
- DEF 14A Proxy statement2026-03-24
2026 proxy: board slate, exec comp and auditor ratification ahead of annual meeting
- 8-K Officer / director change2026-02-25
FY2025 record: revenue +25%, EPS +51%, ROE 29.8%, equity $2.82B
- 10-K Annual report2026-02-25
FY2025 record: revenue +25%, EPS +51%, ROE 29.8%, equity $2.82B
- 8-K Earnings results2026-02-19
FY2025 earnings: revenue $2.91B (+25%), net income $840M (+37%), EPS $5.55
- 10-Q Quarterly report2025-11-05
Q3 2025 results sustained the FY2025 growth and underwriting profitability
Recent filings
all on EDGAR ↗4Period ending 2026-05-182026-05-20open ↗4Period ending 2026-05-152026-05-19open ↗144Filing2026-05-18open ↗4Period ending 2026-05-132026-05-15open ↗144Filing2026-05-15open ↗SCHEDULE 13G/AFiling2026-05-15open ↗144Filing2026-05-13open ↗4Period ending 2026-05-082026-05-12open ↗144Filing2026-05-08open ↗4Period ending 2026-05-052026-05-07open ↗4Period ending 2026-05-052026-05-07open ↗4Period ending 2026-05-052026-05-07open ↗
Frequently asked
- Is Hamilton Insurance Group, Ltd. (HG) a buy?
- HG currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. Specialty (re)insurer compounding book value at ~30% ROE, trading at 5.9x earnings and ~0.77x book — the market is mispricing durability.
- What is HG's fair value?
- A Modified-Graham model based on HG's SEC fundamentals estimates a fair value of about $210.90. It is an estimate from reported earnings, not a price target.
- Is HG overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, HG currently appears undervalued relative to its SEC-grounded earnings power.
- What is Hamilton Insurance Group, Ltd.'s quality score?
- HG scores 90.29411764705881/100 (grade A+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001593275, latest 10-Q filed 2026-05-06) · EODHD · analysis by claude-code · as of 6/25/2026, 1:45:40 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.